Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Journal of Gynecology Obstetrics and Human Reproduction|February 7, 2026
Successful live birth following robotic-assisted management of a cesarean scar pregnancy: a promising pathwayAntonella Iannaccone, Paul Buderath, Martin W Britten, et al.
Oncotarget|April 8, 2017
ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancerIssam Chebouti, Jan Dominik Kuhlmann, Paul Buderath, et al.
Frontiers in Oncology|March 21, 2022
CAF-Associated Paracrine Signaling Worsens Outcome and Potentially Contributes to Chemoresistance in Epithelial Ovarian CancerMichael Wessolly, Elena Mairinger, Sabrina Borchert, et al.
Plos One|May 9, 2014
Correlation of standardized uptake value and apparent diffusion coefficient in integrated whole-body PET/MRI of primary and recurrent cervical cancerJohannes Grueneisen, Karsten Beiderwellen, Philipp Heusch, et al.
Cancers|August 7, 2021
Image-Based Identification and Genomic Analysis of Single Circulating Tumor Cells in High Grade Serous Ovarian Cancer PatientsCarolin Salmon, Janina Levermann, Rui P L Neves, et al.
Cancer Management and Research|December 10, 2019
Digital Immune-Related Gene Expression Signatures In High-Grade Serous Ovarian Carcinoma: Developing Prediction Models For Platinum ResponseFabian Mairinger, Agnes Bankfalvi, Kurt Werner Schmid, et al.
Scientific Reports|April 2, 2019
HLA-G 3' untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancerEsther Schwich, Vera Rebmann, Rafael Tomoya Michita, et al.
Clinical Chemistry|July 13, 2014
ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum resistanceJan Dominik Kuhlmann, Pauline Wimberger, Agnes Bankfalvi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 8, 2019
Prognostic significance of PD-1 and PD-L1 positive tumor-infiltrating immune cells in ovarian carcinomaPaul Buderath, Fabian Mairinger, Elena Mairinger, et al.
Molecular Oncology|December 24, 2025
Phenotypic and genotypic characterization of single circulating tumor cells in the follow-up of high-grade serous ovarian cancerCarolin Salmon, Rui P L Neves, Nikolas H Stoecklein, et al.
Pageof 7